India Resurgence Fund to acquire API and CRAMS business of Ind-Swift Laboratories for Rs 1,650 cr
The board of directors of Ind-Swift Laboratories Limited on Wednesday approved a business transfer of its active pharmaceutical ingredients (API) ...
Tag: 650 cr
EDITOR'S PICK
